The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Be good business for Ambry imo.
Will Ambry Genetics counter bid. 1.5p to 2p+ is fair value not 0.52p! This Novacyt offer only values YGEN at £16 million. Don't sell yet I would suggest. 75% of shareholders need to agree. Novacyt has only received irrevocable undertakings of approx 26.1 per cent so far. My average down price is 0.30p but I'm holding out for over 1.5p....
Good luck, Brighty
I did davand. Asking for a sale for years and they wait and wait until they deliver this!!!
Absolutely in keeping with their incompetance
Question....
Assuming this is a done deal.
If we can buy say sub 0.4p this morning...should we??
Well twix, you got your wish ..just not the right price.
Isn't it about the figure Rees needs to break even??
This is not even 1x the revenue of the company. Theft 💯
Not at all a fair value. Shareholders should demand at least 2x valuation. I remember back in April 2022 we were shown M&A slides and told us that valuation these days are in the range of 10x - w*f !!
I will take it, averaged down and hold just over one million shares.
Well that's all folks!
THEFT !
A lowball offer from NYCT as expected !!
https://www.actusnews.com/en/amp/novacyt/pr/2023/07/03/recommended-cash-offer-for-yourgene-health-plc
Yourgene Health plc
to be effected by means of a Scheme of Arrangement
under Part 26 of the Companies Act 2006
Summary
· The boards of directors of Novacyt and Yourgene are pleased to announce that they have reached agreement on the terms and conditions of a recommended cash offer to be made by Novacyt UK, a wholly-owned subsidiary of Novacyt, for the entire issued and to be issued share capital of Yourgene (the "Acquisition").
· Under the terms of the Acquisition, each Yourgene Shareholder will be entitled to receive:
0.522 pence in cash per Yourgene Share
Few people called it!
Big investors get it wrong plenty of times too. They didn't have much confidence in the current BOD , hence their insistence on having their own chap in there.
Cant see it given they have run down a perfectly good business unintentionally to the point of failure.
BGF wouldn't back them unless they felt they had potential to recover their full investment
As mentioned, depends what their agenda is rgds decline. Great for a lowball isn't it?
The silence is confusing. Surely a few credible Multiple choice options are all better than continued decline
A. Shout from the roof tops Whats new and coming soon (not more jam tomorrow)
B. Nothing to report just now but........
C. Build up and out from a point of consolidation and outline the recovery plan (BOD remove LR)
D. Trading update or financial plan on a page (how me intend to move forward keeping the lights on)
E. BOD statement on how YGEN has lost 99% of its value (analysis of how this domino car crash evolved)?
Any of the above would be better than looking like this is being done either intentionally or without consequence?
INEX approval was reported as taking 8 -12 weeks so what can we expect between now and then?..........Sweet FA shouts a heckler from the crowd.
Clarky, the same bloke who decimated the company value by 99% is still supposedly in charge. No real wonder the market is not impressed. That's why he's toxic and must go.
Revenue growth is great. But it seems it always costs £1 to make 50p so to speak. Why did they not identify costs savings years ago. Surely it's basic stuff. It's got to this point for them to magically find 25% savings.. All too late imo. Always way too many employees for starters, same with the BOD . Just rank bad management. Delusional some might say. Some big deal reason to rack up employee numbers as if it's some sort of metric for success..
If that was the case then BGF won't be investing and company won't be able to raise capital.
Also, if you look at the financials revenue has grown from 6.15Mn in 2018 to 37.56Mn (excluding covid 19Mn). I think with Ranger we have a good potential to get back to growth path. Scott Sargent has a rich industry experience - i hope he can close some big deals in US soon!!
They will not sell their gravy train, why would they? The salaries they pay themselves is bang out of order for their performance. They are toxic and damaging the company and need to go.
Market dont trust the BOD or believe there is a viable business plan or this would be heading up not down IMO
Though this sale of Taiwan unit was a big achievement IMO which was done at 2x valuation.
Considering Yourgene current revenue of 20Mn and expected 20% growth we can expect 2024 revenue in the circa of 22Mn.
So, it would easily command an enterprise valuation of 44Mn compare to our current market cap of just 7Mn.
Best would be to sell this company to some big corporation and save the current shareholders !!
Learning via bitter experience that "analysts forecasts" are at best unreliable.
The debt capital ratio is a bit high for me but in other respects YGEN looks a viable punt yet sp is sliding towards zero.
Already stated due to market conditions on the world of qualify CFOs we will have to wait???🧐 what for what and how long???
Dont suppose they will want to face done questions from an investors presentation this time lol 😳
Manchester, UK - 11 July 2022: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that its audited final results for the year ended 31 March 2022 will be issued on Wednesday 27 July 2022.
Investor briefing
Lyn Rees, Chief Executive Officer and Barry Hextall, Chief Financial Officer, will provide a live presentation relating to the Company's final results for the year ended 31 March 2022 via the Investor Meet Company platform on Wednesday 27 July 2022 at 4:30pm BST.